Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne Wagner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|October 29, 2020
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM RegistryRafat Abonour, Robert M Rifkin, Cristina Gasparetto, et al.
Contemporary Clinical Trials|March 26, 2026
Corrigendum to 'Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial trial' [Contemporary Clinical Trials, Vol. 149 (2025) 107783]John M Salsman, Karly M Murphy, Elizabeth L Addington, et al.
Blood Cancer Journal|July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM RegistryHans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Cancer Medicine|May 1, 2021
Patient perspectives on chemotherapy de-escalation in breast cancerGabrielle B Rocque, Courtney P Williams, Courtney Andrews, et al.
JMIR Formative Research|May 14, 2025
Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing StudyPhillip Trieu, Dominique Fetzer, Briana McLeod, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2021
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM RegistryCristina Gasparetto, Sundar Jagannath, Robert M Rifkin, et al.
Pilot and Feasibility Studies|January 14, 2025
Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatmentJuliana V Costa, Alexander R Lucas, Shannon L Mihalko, et al.
Cancer|July 25, 2020
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysisSikander Ailawadhi, Sundar Jagannath, Hans C Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2020
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM RegistrySundar Jagannath, Robert M Rifkin, Cristina J Gasparetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 29, 2020
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM RegistryRafat Abonour, Robert M Rifkin, Cristina Gasparetto, et al.
Contemporary Clinical Trials|March 26, 2026
Corrigendum to 'Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial trial' [Contemporary Clinical Trials, Vol. 149 (2025) 107783]John M Salsman, Karly M Murphy, Elizabeth L Addington, et al.
Blood Cancer Journal|July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM RegistryHans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Cancer Medicine|May 1, 2021
Patient perspectives on chemotherapy de-escalation in breast cancerGabrielle B Rocque, Courtney P Williams, Courtney Andrews, et al.
JMIR Formative Research|May 14, 2025
Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing StudyPhillip Trieu, Dominique Fetzer, Briana McLeod, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2021
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM RegistryCristina Gasparetto, Sundar Jagannath, Robert M Rifkin, et al.
Pilot and Feasibility Studies|January 14, 2025
Feasibility and preliminary efficacy of a physical activity intervention in adults with lymphoma undergoing treatmentJuliana V Costa, Alexander R Lucas, Shannon L Mihalko, et al.
Cancer|July 25, 2020
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysisSikander Ailawadhi, Sundar Jagannath, Hans C Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2020
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM RegistrySundar Jagannath, Robert M Rifkin, Cristina J Gasparetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Pageof 5